Case 1:20-cr-00330-PAE Document 387 Filed 10/29/21 Page 16 of 21

The government’s modus operandiargument appears fo rest. on, the premise that
“srooming,” howéver broadly that may be: défined, constitutes a distinctive pattern of criminal
activity. See id.4 As the,government itself pointed out, the characteristics ofthe modus operandi
must be “sufficiently idiosyncratic to permit'a, fair inference: of a, pattern’s existence.” United
States v. .Sliker, T51,.F.2d 477, 487 (2d: Cir. 1984)); see also, United States. v: Walia, No. 14-CR-
2.13. (MKB), 2014 WL 3734522, at *13 (S.D.N.Y.. July: 25,2014) (“Rule 404(b) permits evidence
of similar acts to:prove.a. ‘signature crime,’ i.¢-,,a. modus operandi where the crimes are ‘so
nearly ‘identical :in method as to ‘car-mark.them.as the.handiwork of the accused.’” (quoting

United States v» Mills, 895. F.2d 897, 907 (2d Cir. 1990)). Here, Accuser-3 alleges that| __]

| as she is alleged to have:done with the other
accusers. Gov’t Mem. in Opp. to Def.’s Pretrial Motions (Dkt. 204) at 158. But engaging in
‘social pleasantries and polite conversation docs not in any way cstablish'a, unique or “signature”
pattern of behavior. Sée Walid, 2014 WL 3734522, at *13 (prior acts that share. similarities with
the charged offenses do not.establish a modus operandi without a “signature” pattern ‘of conduct)
(collecting cases). In'sum, Accuscr-3’s evidence will not be offered for any*permissible purpose
under. Rule 404(b) and will just serve as cvidence ‘of criminal propensity: The Court should
therefore excludc it.

The Court should also, exclude Accuser-3’s Evidence under Rulé 403 because it will
unfairly-prejudice Ms..Maxwell and mislead the jury as to the legality.of the alleged conduct and.
the purpose of its admission. Rule 403 provides that relevant evidence “may be exeluded if its

probative Valuc.is substantially‘outweighed by the danger of unfair prejudice, confusion. of the

+ Ms. Maxwell-hasinioved separately to exclude:the testimony ofthe government’s proposed. expert witness
‘concerning “grooming” under Federal Rules of Evidence:401, 402, 403, 404, 702, 704, and Daubert. Merrell. Dow
Pharmaceuticals, Iné.,, 509 U.S.'579 (1993).

DOJ=OGR-00005680
